William Wierda, MD, PhDEnriched profile
Professor of Medicine (Leukemia); Deputy Department Chair, Department of Leukemia; Executive Medical Director, Inpatient Medical Services; Section Chief, Chronic Lymphocytic Leukemia; Center Medical Director, Leukemia Center; Jane and John Justin Distinguished Chair in Leukemia Research in Honor of Dr. Elihu Estey (2022–Present) · The University of Texas MD Anderson Cancer Center, Houston, TX, Department of Leukemia, Division of Cancer Medicine
Overview
Updated 14 Jul 2026
William G. Wierda is Professor of Medicine (Leukemia) at The University of Texas MD Anderson Cancer Center, Houston, TX, Department of Leukemia, Division of Cancer Medicine. The public record shows 1,533 publications with 63,208 citations (h-index 122), centered on Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Acute Lymphoblastic Leukemia research. It also documents an investigator role on 18 registered clinical trials, 2 NIH-funded awards (2009–2014).
- Most recent indexed publication: 2026 · Blood
- Top research focus: Chronic Lymphocytic Leukemia Research
- 18 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 44 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 587.
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 19 registered studies on ClinicalTrials.gov. The most recent:
- Acalabrutinib and Venetoclax With or Without Early Obinutuzumab for the Treatment of High Risk, Recurrent, or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Sponsor: M.D. Anderson Cancer Center
InvestigatorPhase 2RecruitingNCT04169737 - Trabectedin and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Resistant or Intolerant to a BTK Inhibitor
Sponsor: M.D. Anderson Cancer Center
InvestigatorPhase 1WithdrawnNCT03884972 - Study of Adoptive Cellular Therapy Using Autologous T Cells Transduced With Lentivirus to Express a CD33 Specific Chimeric Antigen Receptor in Patients With Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia
Sponsor: M.D. Anderson Cancer Center
InvestigatorPhase 1TerminatedNCT03126864
Industry payments
14 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
No payments involving this person were reported to CMS in program years 2021–2024. Why? →
NIH funding
Updated 14 Jul 2026
2 NIH research awards on record, funded 2009–2014 per NIH RePORTER. The latest:
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Reply to: How to Interpret the Results in a Noninferiority Randomized Trial in Chronic Lymphocytic Leukemia.
Journal of clinical oncology
2026
Most-cited worksby citation count (OpenAlex)
- 01
- 02Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia2,249 citations2013
- 03Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors2,145 citations2020
- 04Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia1,887 citations2015
- 05Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia892 citations2015
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
Editorial & leadership rolesjournal and society appointments
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
Secondary affiliationsappointments beyond the home institution
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →faculty.mdanderson.org ↗
- Faculty
Chronic Lymphocytic Leukemia Research Consortium (CRC), UC San Diego
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cll.ucsd.edu ↗
Media & interviewspress, podcasts and appearances
- OncLive contributor/video series
recurring expert commentary on CLL treatment (BTK inhibitors, MRD-guided therapy, 17p deletion management)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗ - Patient Power video interviews
CLL diagnostic workup, prognostic factors, and treatment options, with hosts Michele Nadeem-Baker and Jeff Folloder
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →patientpower.info ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mdanderson.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/william-wierda-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/william-wierda-77014510
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - LinkedIn
linkedin.com/in/william-wierda-b1915616
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
Mentions by otherswhere others cite or feature them
- Other
cllglobal.org/cll-global-research-foundation-president-dr-william-wierda
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cllglobal.org ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Hagop Kantarjian, MD
The University of Texas MD Anderson Cancer Center
- 5,579
- publications
- 233
- h-index
- 24
- trials
Jorge Cortes, MD
Augusta University
- 3,575
- publications
- 180
- h-index
- 67
- trials
Ayalew Tefferi, MD
Mayo Clinic
- 2,093
- publications
- 154
- h-index
- 7
- trials
Charles Sawyers, MD
Memorial Sloan Kettering Cancer Center
- 639
- publications
- 131
- h-index
- 4
- trials